OTC Healthcare in the Czech Republic
Euromonitor International's OTC Healthcare in the Czech Republic market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 111 | Publication date: Sep 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Market growth healthy
The OTC healthcare market in the Czech Republic posted another good performance in 2007, with growth higher than in the previous year. Sales grew by a healthy 6% in current value terms in 2007. Many Czechs tend to prefer OTC healthcare products due to their good availability through pharmacies and drugstores. Many people consider procedures in outpatients' departments as lengthy and not efficient. Time to visit a doctor has declined because of fast-paced lifestyles and work becoming quite demanding. Rising disposable incomes in the Czech Republic boosted sales also in 2007.
Economy boosts sales
The Czech economy performed well in 2007 and continued to catch up the more developed EU economies. All the basic economic indicators grew at a similar pace as in the previous year. In terms of GDP the country saw 5% growth in comparison to 2006. According to the Czech Statistical Office the country recorded positive trends in terms of inflation, real growth in consumption, disposable incomes and employment and unemployment. Consequently, Czechs tended to purchase more.
Domestic companies perform well
The OTC healthcare market is characterised by the good performances of the local players, two of which are leaders in Central Europe. The top three companies in 2007 were locals – Zentiva, Walmark and Ivax Pharmaceuticals, which combined accounted for 28% of OTC healthcare value sales in 2007. Locals led both major categories of OTC Healthcare – OTC healthcare and nutritionals. The advantages of the domestic companies were good perception of their brands and the usually lower prices than the multinationals’ products.
Pharmacies dominate
Pharmacies continued to dominate the distribution of OTC healthcare products in 2007, although the channel’s value share of sales slightly fell to 78%. The decline was partly due to the liberalisation of OTC healthcare distribution as a broader range of products were allowed to be sold beyond the pharmacies. The internet grew its share of sales as many consumers tent to prefer to purchase online when they know the products they want. Despite this, the dominant position of pharmacies will not be threatened as pharmacists offer consumers professional advice. Most consumers consult the pharmacists before purchasing an OTC healthcare product.
Growth to continue
Sales of OTC healthcare products are predicted to grow by 12% in constant value terms over the 2007-2012 period. Sales will be boosted by the continuation of the review period trends. However, the VAT rate, rising from 5% to 9% in January 2008, will have a strong influence on the market. Another important factor will be additional payments for prescription medicines and for RX, making such products more expensive than many OTC alternatives. As such, experts predict that many Czechs will prefer OTC healthcare products than spending time visiting the doctor and in come cases being prescribed a more expensive RX product.
Table of contents
OTC HEALTHCARE IN THE CZECH REPUBLIC : MARKET INSIGHT
EXECUTIVE SUMMARY
Market growth healthy
Economy boosts sales
Domestic companies perform well
Pharmacies dominate
Growth to continue
KEY TRENDS AND DEVELOPMENTS
New healthcare reform influences sales
Lifestyles boost sales
Internet sales – new distribution phenomenon
Herbal products receive greater attention
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
Table 2 Life Expectancy at Birth 2002-2007
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
Table 5 OTC Healthcare Company Shares by Value 2003-2007
Table 6 OTC Healthcare Brand Shares by Value 2004-2007
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Generics
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - CZECH REPUBLIC
HERBACOS BOFARMA SRO - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Herbacos Bofarma sro: Key Facts
Summary 3 Herbacos Bofarma sro: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Herbacos Bofarma sro: Competitive Position 2007
HERBACOS BOFARMA SRO - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Vitar sro: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Vitar sro: Competitive Position 2007
WALMARK AS - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Walmark as: Key Facts
Summary 8 Walmark as: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Walmark as: Competitive Position 2007
ZENTIVA NV - OTC HEALTHCARE - CZECH REPUBLIC
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Zentiva as: Key Facts
Summary 11 Zentiva as: Operational Indicators
COMPANY BACKGROUND
PRODUTION
COMPETITIVE POSITIONING
Summary 12 Zentiva: Competitive Position 2007
ANALGESICS IN THE CZECH REPUBLIC
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2002-2007
Table 12 Sales of Analgesics by Subsector: % Value Growth 2002-2007
Table 13 Herbal vs Standard Topical Analgesics 2002-2007
Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2007
Table 15 Analgesics Company Shares by Value 2003-2007
Table 16 Analgesics Brand Shares by Value 2004-2007
Table 17 Forecast Sales of Analgesics by Subsector: Value 2007-2012
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE CZECH REPUBLIC
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2002-2007
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2002-2007
Table 21 Sales of Decongestants by Type: Value 2002-2007
Table 22 Sales of Decongestants by Type: % Value Growth 2002-2007
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2002-2007
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2002-2007
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2002-2007
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2003-2007
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2004-2007
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2007-2012
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2007-2012
DIGESTIVE REMEDIES IN THE CZECH REPUBLIC
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2002-2007
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2002-2007
Table 32 Herbal vs Standard Digestive Remedies 2002-2007
Table 33 Digestive Remedies Company Shares by Value 2003-2007
Table 34 Digestive Remedies Brand Shares by Value 2004-2007
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2007-2012
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2007-2012
MEDICATED SKIN CARE IN THE CZECH REPUBLIC
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2002-2007
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2002-2007
Table 39 Herbal vs Standard Medicated Skin Care 2002-2007
Table 40 Acne Treatments by Format: % Value Breakdown 2004-2007
Table 41 Medicated Skin Care Company Shares by Value 2003-2007
Table 42 Medicated Skin Care Brand Shares by Value 2004-2007
Table 43 Acne Treatments Brand Shares by Value 2004-2007
Table 44 Hair Loss Treatments Brand Shares by Value 2004-2007
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2007-2012
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2007-2012
VITAMINS AND DIETARY SUPPLEMENTS IN THE CZECH REPUBLIC
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2002-2007
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2002-2007
Table 49 Sales of Vitamins by Type: Value 2002-2007
Table 50 Sales of Vitamins by Type: % Value Growth 2002-2007
Table 51 Sales of Dietary Supplements by Type: Value 2002-2007
Table 52 Sales of Dietary Supplements by Type: % Value Growth 2002-2007
Table 53 Folic Acid v Other B Vitamins 2004-2007
Table 54 Dietary Supplements by Positioning 2006-2007
Table 55 Vitamins and Dietary Supplements Company Shares by Value 2003-2007
Table 56 Vitamins and Dietary Supplements Brand Shares by Value 2004-2007
Table 57 Vitamins Brand Shares by Value 2004-2007
Table 58 Dietary Supplements Brand Shares by Value 2004-2007
Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2007-2012
Table 60 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2007-2012
NRT SMOKING CESSATION AIDS IN THE CZECH REPUBLIC
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 61 Number of Smokers by Gender 2002-2007
SECTOR DATA
Table 62 Sales of Smoking Cessation Aids by Subsector: Value 2002-2007
Table 63 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2002-2007
Table 64 NRT Gum Flavours 2006-2007
Table 65 Smoking Cessation Aids Company Shares by Value 2003-2007
Table 66 Smoking Cessation Aids Brand Shares by Value 2004-2007
Table 67 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2007-2012
Table 68 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2007-2012
EYE CARE IN THE CZECH REPUBLIC
SECTOR DATA
Table 69 Sales of Eye Care by Subsector: Value 2002-2007
Table 70 Sales of Eye Care by Subsector: % Value Growth 2002-2007
Table 71 Standard Eye Care by Type 2007
Table 72 Eye Care Company Shares by Value 2003-2007
Table 73 Eye Care Brand Shares by Value 2004-2007
Table 74 Forecast Sales of Eye Care by Subsector: Value 2007-2012
Table 75 Forecast Sales of Eye Care by Subsector: % Value Growth 2007-2012
EAR CARE IN THE CZECH REPUBLIC
TRENDS
SECTOR DATA
Table 76 Sales of Ear Care: Value 2002-2007
Table 77 Sales of Ear Care: % Value Growth 2002-2007
Table 78 Ear Care Company Shares by Value 2003-2007
Table 79 Ear Care Brand Shares by Value 2004-2007
Table 80 Forecast Sales of Ear Care: Value 2007-2012
Table 81 Forecast Sales of Ear Care: % Value Growth 2007-2012
ADULT MOUTH CARE IN THE CZECH REPUBLIC
TRENDS
SECTOR DATA
Table 82 Sales of Adult Mouth Care: Value 2002-2007
Table 83 Sales of Adult Mouth Care: % Value Growth 2002-2007
Table 84 Adult Mouth Care Company Shares by Value 2003-2007
Table 85 Adult Mouth Care Brand Shares by Value 2004-2007
Table 86 Forecast Sales of Adult Mouth Care: Value 2007-2012
Table 87 Forecast Sales of Adult Mouth Care: % Value Growth 2007-2012
CALMING AND SLEEPING PRODUCTS IN THE CZECH REPUBLIC
TRENDS
SECTOR DATA
Table 88 Sales of Calming and Sleeping Products: Value 2002-2007
Table 89 Sales of Calming and Sleeping Products: % Value Growth 2002-2007
Table 90 Calming and Sleeping Products Company Shares by Value 2003-2007
Table 91 Calming and Sleeping Products Brand Shares by Value 2004-2007
Table 92 Forecast Sales of Calming and Sleeping Products: Value 2007-2012
Table 93 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012
WOUND TREATMENTS IN THE CZECH REPUBLIC
TRENDS
SECTOR DATA
Table 94 Sales of Wound Treatments by Subsector: Value 2002-2007
Table 95 Sales of Wound Treatments by Subsector: % Value Growth 2002-2007
Table 96 Wound Treatments Company Shares by Value 2003-2007
Table 97 Wound Treatments Brand Shares by Value 2004-2007
Table 98 Forecast Sales of Wound Treatments by Subsector: Value 2007-2012
Table 99 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2007-2012
EMERGENCY CONTRACEPTION IN THE CZECH REPUBLIC
OVERVIEW